Association between GSTM1 polymorphism and nasopharyngeal cancer susceptibility: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5817-5821

  Sun, Zhen Feng ^a   Zhang, Jia ^a   Xu, Hong Ming ^a   Wang, Guo Liang ^a   Dong, Pin ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Analysis; Glutathione S transferase M1; Meta; Nasopharyngeal cancer; Polymorphism

Indexed keywords

EID: 84874070409     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5817     Document Type: Article

References (27)

1. Ahmad ST, Arjumand W, Seth A, et al (2012). Impact of glutathione transferase M1, T1, and P1 gene polymorphisms in the genetic susceptibility of North Indian population to renal cell carcinoma. DNA Cell Biol, 31, 636-43.
2. Attia J, Thakkinstian A, D'Este C (2003). Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol, 56, 297-303.
3. Bendjemana K, Abdennebi M, Gara S, et al (2006). Genetic polymorphism of gluthation-S transferases and N-acetyl transferases 2 and nasopharyngeal carcinoma: the Tunisia experience. Bull Cancer, 93, 297-302.
4. Chan AT (2011). Current treatment of nasopharyngeal carcinoma. Eur J Cancer, 47, S302-3.
5. Chang ET, Adami HO (2006). The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 15, 1765-77.
6. Cheng YJ, Chien YC, Hildesheim A, et al (2003). No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan. Cancer Epidemiol Biomarkers Prev, 12, 179-80.
7. Cochran WG (1950). The comparison of percentages in matched samples. Biometrika, 37, 256-66.
8. Da SJ, Liang B, Wu HL, et al (2002). Relationship between GSTM1 gene polymorphism and genetic susceptibility in nasopharyngeal carcinoma. Prac J Cancer, 17, 617-26 (in Chinese).
9. Deng ZL, Wei YP, Luo W, et al (2005). Glutathione S-transferase M1 and T1 gene deletion associated with increased susceptibility to nasopharyngeal carcinoma. Chin German J Clini Onc, 4, 276-8.
10. Deng ZL, Wei YP, Ma Y (2004). Frequent genetic deletion of detoxifying enzyme GSTM1 and GSTT1 genes in nasopharyngeal carcinoma patients in Guangxi Province, China. Zhonghua Zhong Liu Za Zhi, 26, 598-600 (in Chinese).
11. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
12. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
13. Guo X, O'Brien SJ, Zeng Y, et al (2008). GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese. Cancer Epidemiol Biomarkers Prev, 17, 1760-3.
14. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
15. Ho CK, Lo W CH, Huang PH (1999). Suspected nasopharyngeal carcinoma in three workers with long term exposure to sulphuric acid vapour. Occup Environ Med, 56, 426-8.
16. Jiang Y, Li N, Dong P, et al (2011). Polymorphisms in GSTM1, GSTTI and GSTP1 and nasopharyngeal cancer in the east of China: a case-control study. Asian Pac J Cancer Prev, 12, 3097-100.
17. Liu ZG, Wei YP, Ma Y, et al (2003). Population with GSTT1 gene deletion and the relationship to hepatocellular caecinoma from Guangxi. J Guangxi Med Univ, 20, 161-3 (in Chinese).
18. Mantel N ,Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
19. Md A, J W, A T, et al (1999). Facial artery and atherosclerosis. Folia Morphol (Warsz), 58, 199-206.
20. Moaven O, Raziee HR, Sima HR, et al (2010). Interactions between Glutathione-S-Transferase M1, T1 and P1 polymorphisms and smoking, and increased susceptibility to esophageal squamous cell carcinoma. Cancer Epidemiol, 34, 285-90.
21. Nazar-Stewart V, Vaughan TL, Burt RD, et al (1999). Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 8, 547-51.
22. O'Neil JD, Owen TJ, Wood VH, et al (2008). Epstein-Barr virusencoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J Gen Virol, 89, 2833-42.
23. Stuck AE, Rubenstein LZ ,Wieland D (1998). Bias in metaanalysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ, 316, 469; author reply 70-1.
24. Tiwawech D, Srivatanakul P, Karalak A, et al (2005). Glutathione S-transferase M1 gene polymorphism in Thai nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 6, 270-5.
25. Vrana D, Pikhart H, Mohelnikova-Duchonova B, et al (2009). The association between glutathione S-transferase gene polymorphisms and pancreatic cancer in a central European Slavonic population. Mutat Res, 680, 78-81.
26. Wei YP, Long XD, Liu ZG, et al (2012). Genetic polymorphism of glutathione-S-transferase M1 and T1 in associated with carcinogenesis of hepatocellular carcinoma and nasopharyngeal carcinoma. Chin German J Clini Onc, 11, 138-41.
27. Zhuo XL, Cai L, Xiang ZL, et al (2009). GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. J Exp Clin Cancer Res, 28, 46.